G730-0771 Screening compound: N~3~-(3,4-dimethoxyphenethyl)-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide

G730-0771 Screening compound: N~3~-(3,4-dimethoxyphenethyl)-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide
G730-0771 Screening compound: N~3~-(3,4-dimethoxyphenethyl)-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G730-0771
N~3~-(3,4-dimethoxyphenethyl)-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G730-0771

Molecular Formula

C23H27N3O3 (C23 H27 N3 O3)

Compound Name

N~3~-(3,4-dimethoxyphenethyl)-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide

IUPAC name

N-[2-(34-dimethoxyphenyl)ethyl]-18-diazatricyclo[7.5.0.0^{27}]tetradeca-2(7)358-tetraene-5-carboxamide

SMILES

COc(ccc(CCNC(c(cc1)cc2c1n(CCCCC1)c1n2)=O)c1)c1OC

InChI

InChI=1S/C23H27N3O3/c1-28-20-10-7-16(14-21(20)29-2)11-12-24-23(27)17-8-9-19-18(15-17)25-22-6-4-3-5-13-26(19)22/h7-10,14-15H,3-6,11-13H2,1-2H3,(H,24,27)

InChI Key

WBIOCVRGEAGTLC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15030571

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

393.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.902

Distribution Coefficient, logD

2.900

Water Solubility, LogSw

-3.26

Polar Surface Area

51.286

Acid Dissociation Constant (pKa)

13.12

Base Dissociation Constant (pKb)

5.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.10

G730-0771 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Protein-Protein Interaction Library (218420 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with G730-0771 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G730-0771?
Check Price and Availability of G730-0771, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G730-0771 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G730-0771
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G730-0771
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G730-0771 available by request